Showing results (71-80 of 693) with videos related to
Sort By:
Pageof 70
Chinese Clinical Oncology|June 29, 2021
Characteristics of Asian 4 countries on cancer clinical trials registered in the International Clinical Trials Registry Platform between 2005 and 2018Mariko Doi, Keiko Yukawa, Hajime SatoChinese Clinical Oncology|June 13, 2021
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial resultsLauren S Singer, Alexander Z Feldman, Robin A Buerki, et al.Chinese Clinical Oncology|February 4, 2020
Interventional radiology approaches for intra-hepatic cholangiocarcinomaCristina Mosconi, Marco Calandri, Milind Javle, et al.Chinese Clinical Oncology|December 23, 2020
Narrative review of sentinel lymph node biopsy in breast cancer: a technique in constant evolution with still numerous unresolved questionsCarole Mathelin, Massimo LodiChinese Clinical Oncology|March 23, 2021
A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgerySatoshi Hirano, Yoshimasa Gohda, Hideki Miyazaki, et al.Chinese Clinical Oncology|November 15, 2021
Radiation therapy in the prevention and management of brain metastases in patients with small cell lung cancer: a narrative reviewEric Hau, Rebecca Lim, Shalini Vinod, et al.Chinese Clinical Oncology|November 22, 2021
Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative reviewMiral M Patel, Huong T Le-PetrossChinese Clinical Oncology|September 13, 2022
Non-colorectal non-neuroendocrine liver metastasis: a narrative review of surgical treatmentCeleste Del Basso, Sofia Usai, Giovanni Battista Levi SandriChinese Clinical Oncology|October 21, 2021
What is the best systemic treatment for newly diagnosed inflammatory breast cancer?-a narrative reviewSudpreeda Chainitikun, Siyamol Mingmalairak, Napa ParinyanitikulChinese Clinical Oncology|September 6, 2018
Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areasThomas Ohnleiter, Delphine Antoni, François Lefebvre, et al.Pageof 70